Tumour marker concentration at the start of chemotherapy is a stronger predictor of treatment failure than marker half-life: a study in patients with disseminated nonseminomatous t... by DE WIT, R, SYLVESTER, R, STOTER, G, TSITSA, C, DE MULDER, P. H. M, SLEYFER, D. T, TEN BOKKEL HULNINK, W. W, KAYE, S. B, VAN OOSTEROM, A. T, BOVEN, E, VERMEYLEN, K

Get full text